MoneyWorks4Me

Dishman’s Bavla unit completes Japanese PMDA audit

07 Dec 2017 Evaluate

Dishman Carbogen Amcis’ manufacturing plant in Bavla, Gujarat, India has successfully passed the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) audit without any observations. This development is again a testimony to the strong focus the company lays on their quality systems and processes.

Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..